Skip to main content

Advertisement

SpringerLink
Log in

High CCR5 expression in natalizumab-associated progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome supports treatment with the CCR5 inhibitor maraviroc

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Giacomini PS, Rozenberg A, Metz I, Araujo D, Arbour N, Bar-Or A; Maraviroc in Multiple Sclerosis-Associated PML–IRIS (MIMSAPI) Group (2014) Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome. N Engl J Med 370:486–488. doi:10.1056/NEJMc1304828

    Article  Google Scholar 

  2. Martin-Blondel G, Cuzin L, Delobel P, Cuvinciuc V, Dumas H, Alvarez M, Massip P, Marchou B (2009) Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management? AIDS 23:2545–2546. doi:10.1097/QAD.0b013e32833365f4

    Article  PubMed  Google Scholar 

  3. Metz I, Radue EW, Oterino A, Kümpfel T, Wiendl H, Schippling S, Kuhle J, Sahraian MA, Gray F, Jakl V, Häusler D, Brück W (2012) Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathol 123:235–245. doi:10.1007/s00401-011-0900-5

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Trebst C, Staugaitis SM, Tucky B, Wei T, Suzuki K, Aldape KD, Pardo CA, Troncoso J, Lassmann H, Ransohoff RM (2003) Chemokine receptors on infiltrating leucocytes in inflammatory pathologies of the central nervous system (CNS). Neuropathol Appl Neurobiol 29:584–595

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

IM and WB were supported by grants from the German Ministry for Education and Research (BMBF, ‘‘German Competence Network Multiple Sclerosis’’ (KKNMS), Pattern MS/NMO).

Author information

Authors and Affiliations

  1. Department of Neuropathology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany

    Lidia Stork, Wolfgang Brück & Imke Metz

  2. Department of Neurology and Neurosurgery and Neuroimmunology Unit, Montreal Neurological Institute, McGill University, Montreal, Canada

    Amit Bar-Or

Authors
  1. Lidia Stork
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolfgang Brück
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amit Bar-Or
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Imke Metz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Imke Metz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stork, L., Brück, W., Bar-Or, A. et al. High CCR5 expression in natalizumab-associated progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome supports treatment with the CCR5 inhibitor maraviroc. Acta Neuropathol 129, 467–468 (2015). https://doi.org/10.1007/s00401-015-1391-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-015-1391-6

Keywords

Search

Navigation